
About Biogenuix
Biogenuix is a Healthcare company based in Delhi (India) founded in 2004 by Sundeep Amar and Ashish Bawa. It provides research reagents for clinical diagnostics and life science research. It operates on a B2B model. The company has 32 employees. Its Indian entity Biogenuix Medsystems Private Limited reported revenue of βΉ17.81 Cr. Its focus areas include Biotechnology, Research Reagents and Clinical Diagnostics.
Company details
Biogenuix operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, research reagents, and clinical diagnostics. Provides research reagents for clinical diagnostics and life science research. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Delhi, India
- Employees 32
- Founders Sundeep Amar, Ashish Bawa
- SectorsHealthcare
- Website biogenuix.com
- Social LinkedIn Facebook
- Legal Name Biogenuix Medsystems Private Limited
- Date of Incorporation 13 Feb, 2007
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹17.81 Cr
FY 2025 · +7% YoY
- Net Profit₹1.28 Cr
FY 2025 · 7% margin
- EBITDA₹2.04 Cr
FY 2025 · 11% margin
- Employee Count32
Associated legal entities of Biogenuix
Biogenuix operates through Biogenuix Medsystems Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biogenuix Medsystems Private Limited CIN U85191DL2007PTC159208 | Active | 13 Feb 2007 | New Delhi, Delhi | ₹17.8 Cr | 32 | 6 | View details |
Board of directors of Biogenuix Medsystems Private Limited (Biogenuix)
Biogenuix Medsystems Private Limited is the primary company behind Biogenuix. The board of Biogenuix Medsystems Private Limited currently have 6 directors; the longest-serving is Ashish Bawa, appointed in 2007. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashish Bawa DIN 01956399 | Director | 13 Feb 2007 | 19 yrs 8 mo | Biogenuix Medsystems Private Limited |
| Sundeep Amar DIN 01956366 | Director | 13 Feb 2007 | 19 yrs 8 mo | Biogenuix Medsystems Private Limited |
| Nina Amar DIN 02263356 | Director | 01 Jul 2008 | 18 yrs 3 mo | Biogenuix Medsystems Private Limited |
| Anjali Bawa DIN 02263391 | Director | 01 Jul 2008 | 18 yrs 3 mo | Biogenuix Medsystems Private Limited |
| Vertika Shrivastava DIN 06610813 | Director | 01 Nov 2014 | 11 yrs 11 mo | Biogenuix Medsystems Private Limited |
| Anil Shrivastava DIN 03009771 | Director | 01 Nov 2014 | 11 yrs 11 mo | Biogenuix Medsystems Private Limited |
People of Biogenuix
2 people are tracked at Biogenuix (2 in leadership); the tracked headcount is 32.
| Name | Role | Group |
|---|---|---|
| Co-Founder, Director | Leadership | |
| Co-Founder, Director | Leadership |
Complete people profiles for Biogenuix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Biogenuix
Figures of Biogenuix Medsystems Private Limited, the primary company behind Biogenuix, for FY 2025. Revenue was ₹17.81 Cr (+7% year on year). Net profit was ₹1.28 Cr (7% margin). EBITDA was ₹2.04 Cr (11% margin). Revenue has grown at a compounded annual rate of -3% over three years and 0% over five years.
- ₹17.81 CrRevenue · FY 2025 · +7% YoY
- ₹1.28 CrNet profit · 7% margin
- ₹2.04 CrEBITDA · 11% margin
- ₹1.1 LakhPaid-up capital
- 32Employees (provident fund records)
- -3%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Biogenuix Medsystems Private Limited are on its company page.
Detailed financial statements for Biogenuix
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Biogenuix
The website of Biogenuix (biogenuix.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 18.9% vs previous month
Websites whose visitors overlap most with Biogenuix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| usbio.com | 100% | – | – | View details | |
| resorg.com | 100% | – | – | View details | |
| bioatlas.com | 98% | – | – | View details | |
| panomics.com | 91% | – | – | View details | |
| dcndx.com | 81% | 8.6K | #2,703,307 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 6 similar websites and full traffic analytics for Biogenuix
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diagnostics & Lab Tech
10 companies that operate in the same segment as Biogenuix (Diagnostics & Lab Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | Basel, Basel-stadt, Switzerland | – | USD 77.61 B | 103,250 | |
At-home health tests for biomarkers, nutrition, and hormone analysis. | 2014 | Austin, Texas, United States | USD 330 M | – | 336 | |
Point-of-care and laboratory blood analyzers are developed by EKF. | 1990 | Penarth, Wales, United Kingdom | USD 178.63 K | USD 69.43 M | 303 | |
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | – | – | |
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | – | USD 4.45 M | 54 | |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed. | 2002 | Hennigsdorf, Brandenburg, Germany | USD 36.14 M | – | – | |
Diagnostic instrumentation and assays | 1987 | Puteaux, Hauts-de-seine, France | – | – | – | |
Manufacturer of Laboratory equipment | 1955 | Norwood, Massachusetts, United States | – | – | – | |
Cloud based diagnostics platform for point of care diagnosing | 2014 | Waltham, Massachusetts, United States | USD 703.91 M | USD 115.02 K | 9 | |
Diagnostics technology for infectious diseases and health monitoring is provided. | 2012 | Hong Kong, China | USD 34 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biogenuix
Biogenuix was founded in 2004.
Biogenuix is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Biogenuix has 32 employees.
The primary company behind Biogenuix, Biogenuix Medsystems Private Limited, reported revenue of βΉ17.81 Cr for FY 2025, up 7% year on year.
Biogenuix operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, research reagents, and clinical diagnostics. Provides research reagents for clinical diagnostics and life science research. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Biogenuix operates through Biogenuix Medsystems Private Limited.
The legal entities of Biogenuix currently have 6 directors, including Vertika Shrivastava, Ashish Bawa, Sundeep Amar and others.